1. Home
  2. FEMY

as 05-30-2025 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
-
.
-
-
%

Stocks

Health Care

Medical/Dental Instruments

Nasdaq

Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.

Founded: 2004 Country:
United States
United States
Employees: N/A City: SUWANEE
Market Cap: 28.3M IPO Year: 2021
Target Price: $8.67 AVG Volume (30 days): 271.4K
Analyst Decision: Strong Buy Number of Analysts: 3
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.91 EPS Growth: N/A
52 Week Low/High: $0.82 - $1.80 Next Earning Date: 05-08-2025
Revenue: $1,699,232 Revenue Growth: 61.97%
Revenue Growth (this year): 441.89% Revenue Growth (next year): 83.88%

FEMY Daily Stock ML Predictions

Share on Social Networks: